Ruolin Li
Key Laboratory Of Clinical Laboratory Medicine Of Guangxi Department Of Education
Nanning, China
Nanning, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Comparative Evaluation of the Mindray BS2000 and Roche Cobas 8000 Platforms using Serum HDL-C, LDL-C, Apo A1, Apo B, PA, and Fs-CRP.
Journal: Annals of clinical and laboratory science
Published: November 18, 2025
Nutritional and Flavor Improvement of Enzymatic Hydrolysis in Liquefied-Saccharified Foxtail Millet Syrup: Differences Between Drought-Resistant and High-Yield Hybrid Cultivars.
Journal: Journal of food science
Published: October 30, 2025
Beyond ISS staging: the prognostic value of the Inflammation Prognostic Score Index (IPSI) in multiple myeloma.
Journal: Hematology (Amsterdam, Netherlands)
Published: September 01, 2025
Comparing two different doses of anti-thymocyte globulin in allogeneic hematopoietic stem cell transplantation for transfusion-dependent thalassemia: an open-label, randomized clinical trial.
Journal: Therapeutic advances in hematology
Published: August 07, 2025
Expression and Clinical Significance of BCL2 Interacting Protein 3 Like (BNIP3L) in Serum of Patients with MM.
Journal: Blood and lymphatic cancer : targets and therapy
Published: July 30, 2025
Basiliximab in the Prophylaxis of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Thalassemia Major: A Prospective, Multicenter, Open-Label, Randomized Controlled Study.
Journal: American journal of hematology
Published: July 09, 2025
Serum ATIC Expression as a Novel Diagnostic and Prognostic Biomarker in Multiple Myeloma Patients.
Journal: Blood and lymphatic cancer : targets and therapy
Published: May 31, 2025
Identification of Potential Ferroptosis Biomarkers in Multiple Myeloma via WGCNA and Experiments.
Journal: Cancer reports (Hoboken, N.J.)
Published: October 17, 2024
Association between BCL2 interacting protein 3 like (BNIP3L) genetic polymorphisms and the risk of multiple myeloma in China.
Journal: Hematology (Amsterdam, Netherlands)
Published: June 27, 2024
5-Amino-4-Imidazolecarboxamide Ribonucleotide Transformylase/IMP Cyclohydrolase Polymorphisms Affect the Susceptibility to Multiple Myeloma.
Journal: Laboratory medicine
Published: April 09, 2022
Expression and Clinical Significance of BCL2 Interacting Protein 3 Like in Multiple Myeloma.
Journal: Technology in cancer research & treatment
Published: June 30, 2021
Association of Growth Differentiation Factor-15 Polymorphisms and Growth Differentiation Factor-15 Serum Levels with Susceptibility to Multiple Myeloma in a Chinese Population.
Journal: Clinical laboratory
Published: January 25, 2021
Last Updated: 09/26/2026